Nonetheless, despite these limitations, our study revealed that dynamic change of CT-based radiomic texture features between baseline and a few cycles post-treatment of HR + , HER2- breast cancer patients with liver metastasis can predict early response and OS to CDK4/6i coupled with ET. Here, ERBB2 is linked to breast cancer.